Lung Cancer Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Lung Cancer Video Library Mandarin - Rapid Progression Through First Line Treatment What Next
.mp4 Author: cancergrace Added: 06/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Video Library Mandarin - Immunotherapy in Stage III NSCLC PACIFIC Trial and Imfinzi
.mp4 Author: cancergrace Added: 06/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Video Library Mandarin - Immunotherapy Combos in Adv Squamous Non Small Cell Lung Cancer
.mp4 Author: cancergrace Added: 06/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Video Library Mandarin - Immunotherapy Combos in Adv Non Squamous NSCLC
.mp4 Author: cancergrace Added: 06/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Video Library Mandarin - Evolving Standards for Molecular Testing in Advanced NSCLC
.mp4 Author: cancergrace Added: 06/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Video Library Mandarin - Does Immunotherapy Work with Driver Mutations like EGFR ALK
.mp4 Author: cancergrace Added: 06/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Health-related quality of life (HRQoL) results from ALTA-1L: Phase 3 study of brigatinib vs crizotinib as first-line (1L) ALK therapy in advanced ALK+ non-small cell lung cancer (NSCLC).
 Dr. Sanjay Popat, PhD, dicusses Health-related quality of life results from ALTA-1. Background: Results from ALTA-1L (NCT02737501), an international, multicenter trial, showed that brigatinib vs ... Author: Annual-Meeting Added: 06/06/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 6, 2019 Category: Cancer & Oncology Source Type: podcasts

What Is EGFR Exon 20 Insertion Mutant NSCLC: 15% Of Lung Cancer In The United States, 50% Overall In Asian Countries
Joel Neal MD Of Stanford University Medical Center Discusses What Is EGFR Exon 20 Insertion Mutant NSCLC: 15% Of Lung Cancer In The United States, 50% Overall In Asian Countries. Author: Annual-Meeting Added: 06/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer On The Rise: Understanding Why People Are Getting Diagnosed At Earlier Ages Is Important For Prevention & Cure
Karen Reckamp MD @KarenReckampMD Of City of Hope Discusses Lung Cancer On The Rise: Understanding Why People Are Getting Diagnosed At Earlier Ages Is Important For Prevention & Cure. BACKROU... Author: Annual-Meeting Added: 06/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 5, 2019 Category: Cancer & Oncology Source Type: podcasts

Germline Mutations In Patients With Lung Cancer: Study Had 104 Patients Who Were Non Smokers & 65 Who Smoked, Looked At 4 Categories Of Germline Gene Mutation
Karen Reckamp MD @KarenReckampMD Of City of Hope Discusses Germline Mutations In Patients With Lung Cancer: Study Had 104 Patients Who Were Non Smokers & 65 Who Smoked, Looked At 4 Categories Of Germl... Author: Annual-Meeting Added: 06/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 5, 2019 Category: Cancer & Oncology Source Type: podcasts

Leora Horn, MD, MSc, FRCPC - The Present and Future of Immunotherapy as a Key Component of the Treatment Arsenal for Locally Advanced & Earlier Stages of Lung Cancer
Go online to PeerView.com/DHV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Immune checkpoint inhibitor therapy is the new standard of care for patients with stage III, unresectable NSCLC who have not had disease progression after concurrent chemoradiotherapy. Immunotherapy-based treatment approaches are also being explored in multiple clinical trials in neoadjuvant and adjuvant settings in earlier stages of lung cancer. What is the rationale for and the evidence supporting the use of immunotherapy in locally advanced and early-stage lung cancer? How can we optimally...
Source: PeerView CME/CE Audio Podcast - Oncology - May 29, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

SLCVL Calles 5 Appropriate treatment - elderly pts. w adv. NSCLC does age alter recommendations
 GRACE - Global Resource for Advancing Cancer Education Published on Dec 7, 2016 Spanish Lung Cancer Library: Antonio Calles, MD, Medical Oncologist, Thoracic Oncology Program, Hospital General U... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts

SLCVL - Santana-Davila 1 Basics of Lung Cancer Staging
GRACE - Global Resource for Advancing Cancer Education Published on Oct 25, 2016 Dr. Rafael Santana-Davila, Assistant Professor of Medicine at the University of Washington, Seattle Cancer Care All... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts

SLCVL - Hunis 8 Treating Later Stage Small Cell Lung Cancer
 GRACE - Global Resource for Advancing Cancer Education Published on Dec 28, 2016 Spanish Lung Cancer Library: Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, memorial Cancer Ins... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts

SLCVL - Hunis - 1 Risk factors for lung cancer
 GRACE - Global Resource for Advancing Cancer Education Published on Dec 12, 2016 Spanish Lung Cancer Library: Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, Memorial Cancer Ins... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts